IM Cannabis Corp.

IMCC • Drug Manufacturers - Specialty & Generic

$1.42

▲ +0.02 (+1.43%)

Current price

EarningsLatest report: Jun 30, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$13.90M

Growth

-11.5%

Cash Flow

1/5

Trend

Volatile

Evidence

Positive free cash flow · 1.11Weak liquidity · 0.67Weak profitability

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:24 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.42

Change1.43%

Shares Out9.27M

Market Cap$13.90M

52W Range0.09 - 2.61

Beta2.06

P/E-6.57

P/S6.90

P/B-8.65

P/FCF-105.75

EV/Sales2.66

EV/EBITDA-19.61

Price$1.42

Change1.43%

Shares Out9.27M

Market Cap$13.90M

52W Range0.09 - 2.61

Beta2.06

P/E-6.57

P/S6.90

P/B-8.65

P/FCF-105.75

EV/Sales2.66

EV/EBITDA-19.61

EV/FCF-40.82

Earnings Yield-3.80%

FCF Yield-0.95%

Dividend Yield0.00%

Gross Margin17.70%

Oper. Margin-21.17%

Profit Margin-20.68%

Debt/Eq-18.96

Current Ratio0.67

Quick Ratio0.54

Revenue 5Y-11.46%

Volume1.13M

Avg Volume4.37M

EPS Surprise-0.95

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

20/100

Growth Potential

Revenue and expansion

62/100

Price Attractiveness

Cheap or expensive today

95/100

Why this score▼

Positive free cash flow · 1.11Weak liquidity · 0.67Weak profitability

Analyst view

Analyst sentiment and price target

IMCC

Analyst sentiment

Based on 1 analyst votes · 2026-10-20

100/100

Bullish

Hold

Bearish

Company Overview

IPO: 5/20/2020

Industry: Drug Manufacturers - Specialty & Generic

P/B i: -8.65

Debt / Equity i: -18.96

Operating Margin: -21.17%

Net Margin: -20.68%

ROE i: -

ROIC: -

Financial Health

Score4 / 20

Debt / Equity: -18.96

Current Ratio: 0.67

Quick Ratio: 0.54

Status: HighRisk

Warnings

Weak Liquidity
Weak quick ratio

🧾

No insider activity

No recent insider transactions available.

About the Company

IM Cannabis Corp.

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Source - link

Peers

AKAN FLGC GRI JAGX MOVE NAOV NDRA RDHL SHPH VERO

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet

Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' Equity VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company") (NASDAQ: IMCC), today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") among the Company, Slil.com Holding Ltd.

PRNewsWire

IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares

VANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of its previously announced registered direct offering (the "Offering"), pursuant to which the Company sold and issued 655,000 common shares, no par value per share (the "Common Shares"), to certain accredited investors at a purchase price of US$2.00 per Common Share, resulting in aggregate gross proceeds to the Company of US$1.31 million, before deducting offering expenses.

PRNewsWire

IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement

VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that on September 23, 2026, it received written notice from Nasdaq Stock Market LLC ("Nasdaq"), indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

PRNewsWire

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares

VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has entered into securities purchase agreements with certain accredited investors for the purchase and sale of 655,000 common shares, no par value per share, at a purchase price of US$2.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately US$1.31 million at closing before offering expenses.

PRNewsWire

IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market

The Company has entered a non-binding Letter of Intent to acquire control of Space Defense Innovations LLC, which is engaged in distributing BlueBird Aero Systems' advanced tactical UAS and unique Hybrid Fixed-Wing VTOL-UAS platforms in Europe TORONTO and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), today announced that it has entered into a non-binding Letter of Intent (the "LOI") to acquire 51% of the issued and outstanding equity securities of Space Defense Innovations LLC, a Polish limited liability company ("SDI"), on a fully diluted basis.

PRNewsWire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-03-30	0.08596	-0.86	-0.94596
2025-11-13	-0.02313	-0.54	-0.51687
2025-08-12	-0.13668	-0.07	0.06668
2025-05-15	-0.25468	0.06	0.31468
2025-03-31	-0.39	-0.23	0.16
2024-11-14	-0.7	-0.3	0.4
2024-08-14	-0.84	-0.17	0.67
2024-05-08	-0.96	-0.96	0
2024-03-28	-0.96	-1.08	-0.12
2023-11-13	-0.96	-0.72	0.24
2023-08-14	-0.78	-1.14	-0.36
2023-05-15	-1.2	0.12	1.32